Riskpilot← Back to searchSign inGet full accessKLINIKK STAVANGER AS
ASActiveOrg 981689232Kvalebergveien 21, 4016 StavangerMedical specialists activities · NACE 8622Est. 20003 employees
Revenue 2025
NOK 3,4M
-17% vs 2024
EBITDA margin
1.6%
-71% vs 2024
Equity ratio
76.7%
Financial strength
Net profit 2025
NOK -59K
-168% vs 2024
| Revenue | NOK 3,4M | -17% |
| EBITDA | NOK 55K | -71% |
| Net profit | NOK -59K | -168% |
| Total assets | NOK 3,5M | -9% |
| Equity | NOK 2,7M | -2% |
| Employees | 3 | — |
Legal name
KLINIKK STAVANGER AS
Org number
981689232
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
30. mars 2000
Share capital
NOK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Legevirksomhet, samt hva hermed står i forbindelse, samt å delta i andre selskaper med lignende formål.
Address
Kvalebergveien 21, 4016 Stavanger
Phone
+4751882838
Email
klinikk.stavanger@klinikkstavanger.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 615 | 3 673 | 3 855 | 4 044 | 3 363 |
| Staff expenses | −2 238 | −2 122 | −1 857 | −2 064 | −1 740 |
| EBITDA | 570 | −3 | 277 | 188 | 55 |
| Depreciation & amort. | −73 | −126 | −144 | −118 | −191 |
| EBIT | 497 | −129 | 134 | 70 | −136 |
| Net financials | 36 | 19 | 39 | 50 | 64 |
| Profit before tax | 533 | −110 | 173 | 120 | −72 |
| Tax | 119 | −22 | 45 | 33 | −13 |
| Net profit | 414 | −88 | 127 | 87 | −59 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 13 565 | 3 439 | 3 561 | 3 816 | 3 488 |
| Equity | 2 608 | 2 520 | 2 648 | 2 734 | 2 675 |
| Long-term debt | 0 | 0 | 0 | 137 | 199 |
| Short-term debt | 10 957 | 919 | 914 | 944 | 613 |
| Total debt | 10 957 | 919 | 914 | 1 082 | 812 |
EBITDA margin
1.6%
This company
15.8%
Market median
-90% vs market
20212025
Equity ratio
76.7%
This company
38.2%
Market median
+101% vs market
20212025
Return on equity
-2.2%
This company
18.4%
Market median
-112% vs market
20212025
Net profit margin
-1.8%
This company
8.1%
Market median
-122% vs market
20212025
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LB Deputy Member | Deputy Member | 2000 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2000 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Frekam As
KLINIKK STAVANGER AS Board members of KLINIKK STAVANGER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linda Berg-Larsen | Deputy Member | 0 companies |
| Lars Berg-Larsen | Chairman | 0 companies |